About us

DECOMED is an innovative SME specializing in the conception, design, patenting and commercialization of medical devices. For more than 30 years, it has been a benchmark in the field of biomaterials to meet the needs of oncoplastic and general surgery, combining experience, technology and advanced research.

The Company is certified in device design ensuring innovation and suitability for patenting. The quality and reliability of DECOMED products are recognized by numerous scientific publications, which are the result of intensive research. In the field of breast surgery, the Company has experienced significant growth in its expertise driven by study, passion, and an ongoing dialogue with those who live the field every day.

From the idea to the market release, DECOMED has an interdisciplinary workflow and an extensive distribution network, ensuring support to healthcare professionals at every phase, from the first contact with the device to support in the operating room.

Research, innovation and scientific rigor are the values in which DECOMED recognizes itself and which it transmits daily to each member of the group. Each person with his or her own specialization participates in achieving the goals without ever losing the overall vision.

DECOMED has an organic footprint. The Company’s history revolves around the development of biological matrices for tissue regeneration, with an ongoing commitment to the design of unique and reliable products.

In 2012, BRAXON®, the first porcine acellular dermal matrix for complete breast implant wrapping, was born. Before its introduction, reconstruction was performed by a submuscular or two-stage approach. This involved detachment of the pectoralis major muscle leading to greater invasiveness, functional loss and a longer recovery period.

The adoption of the immediate prepectoral technique with BRAXON® has revolutionized the paradigm by offering numerous advantages: a less invasive procedure, reduced risk of postoperative complications, protection from capsular contracture, a more natural effect, and increased patient satisfaction. This evolution has made prepectoral reconstruction with BRAXON® one of the most cutting-edge approaches in reconstructive breast surgery.